Bank of America Corp Reports New 6.1% Stake in Ironwood Pharmaceuticals Inc

Bank of America Corporation filed a Schedule 13G/A on April 27, 2026, disclosing a 6.1% ownership stake in Ironwood Pharmaceuticals Inc (IRWD). This reflects a significant increase from the previous 0.0% position reported, representing a total of 9,962,355 shares of Class A Common Stock. The filing indicates that the shares are held in the ordinary course of business without the intent to influence or change control of the issuer. Bank of America reported shared voting and dispositive power over the entire share count. The filing was made on behalf of several wholly owned subsidiaries, including BofA Securities, Inc., Bank of America N.A., and Merrill Lynch International. The ownership calculation is based on 163,058,316 outstanding shares as disclosed in the issuer's Form 10-K filed in February 2026. This amendment marks a notable entry into a substantial position for the financial institution.